Three-year follow-up of vaccine response in extremely preterm infants

Pediatrics

Volumn 101, Issue 4 I, 1998, Pages 597-603

  Khalak, Rubia ^a,b   Pichichero, Michael E ^a   D'Angio, Carl T ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Golisano Childrens Hospital at Strong   (United States)

Author keywords

Diphtheria tetanus pertussis vaccine; Haemophilus influenzae type b vaccine; Hepatitis B vaccine; Immunization; Polio vaccine

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEMAGGLUTININ; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; TETANUS ANTIBODY; TETANUS TOXOID; VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIMBRIA; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GESTATIONAL AGE; HUMAN; IMMUNE RESPONSE; INFANT; LONG TERM CARE; MALE; NEWBORN; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; SEROTYPING; VACCINATION;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FOLLOW-UP STUDIES; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; INFANT, PREMATURE; POLIOVIRUS VACCINE, ORAL; REFERENCE VALUES; VACCINES;

EID: 0031893689     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.4.597     Document Type: Article

References (37)

1. Peters G, ed. 1997 Red Book. Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:51
2. D'Angio CT, Maniscalco WM, Pichichero ME. Immunologie response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics. 1995;96:18-22
3. Dancis J, Osborn JJ, Kunz HW. Studies of the immunology of the newborn infant. IV. Antibody formation in the premature infant. Pediatrics. 1953;12:151-157
4. Anonymous. Routine immunisation of preterm infants. Lancet. 1990;335: 23-24
5. Pullan CR, Hull D. Routine immunisation of preterm infants. Arch Dis Child. 1989:64:1438-1441
6. Koblin BA, Townsend TR, Munoz A, Onorato I, Wilson M, Polk BF. Response of preterm infants to diphtheria-tetanus-pertussis vaccine. Pediatr Infect Dis J. 1988;7:704-711
7. Smolen P, Bland R, Heiligenstein E, Lawless MR, Dillard R, Abramson J. Antibody response to oral polio vaccine in premature infants. J Pediatr. 1983;103:917-919
8. Bernbaum JC, Daft A, Anolik R, et al. Response of preterm infants to diphtheria-tetanus-pertussis immunizations. J Pediatr. 1985;107:184-188
9. Conway S, James J, Balfour A, Smithells R. Immunisation of the preterm baby. J Infect. 1993;27:143-150
10. Munoz A, Salvador A, Brodsky NL, Arbeter AM, Porat R. Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine. Pediatrics. 1995;96:216-219
11. Washburn LK, O'Shea TM, Gillis DC, Block SM, Abramson JS. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants. J Pediatr. 1993;123:791-794
12. Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr. 1992;120:184-189
13. Weinberg GA, Einhorn MS, Lenoir AA, Granoff PD, Granoff DM. Immunologic priming to capsular polysaccharide-Nrisserifl meningitidis outer membrane protein conjugate vaccine. J Pediatr. 1987;111:22-27
14. Ryan RM, Wagner CL, Schultz JM, et al. Meconium analysis for improved identification of infants exposed to cocaine in utero. J Pediatr. 1994;125:435-440
15. Melville-Smith M, Balfour A. Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test. J Med Microbiol. 1988;25:279-283
16. Simonsen O, Bentzon MW, Heron I. ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand. 1986;14:231-239
17. Meade BD, Deforest A, Edwards KM. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics. 1995;96(suppl):570-575
18. Wood DJ, Heath AB. The second international standard for antipoliovirus sera types 1, 2, and 3. Biologicals. 1992;20:203-211
19. Parker RA, Pallansch MA. Using the virus challenge dose in the analysis of virus neutralization assays. Stat Med. 1992;11:1253-1262
20. Phipps DC, West J, Eby R, et al. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods. 1990; 135:121-128
21. Reizenstein E, Hallander HO, Blackwelder WC, Kuhn I, Ljungman M, Mollby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods. 1995;183:279-290
22. Madore DV, Johnson CL, Phipps DC, et al. Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1-to 6-month-old infants. Pediatrics. 1990;85:331-337
23. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. Norwalk, CT: Appleton and Lange; 1990
24. Craig JP. Immune response to Corynebacterium diphtheriae and Clostridium tetanii. In: Rose NR, Friedman H, Fahey JL, ed. Manual of Clinical Laboratory Immunology. 3rd ed. Washington, DC: American Society for Microbiology; 1986:408-414
25. Orenstein WA, Weisfeld JS, Halsey NA. Diphtheria and tetanus toxoids and pertussis vaccine, combined. In: Halsey NA, deQuadros CA, eds. Recent Advances in Immunization: A Bibliographic Review. Scientific Publication 451. Washington, DC: Pan American Health Organization; 1983: 30-51
26. Santosham M, Hill J, Wolff M, Reid R, Lukacs L, Ahonkai V. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population. Pediatr Infect Dis J. 1991;10: 113-117
27. Kristensen K, Gyhrs A, Lausen B, Barington T, Heilman C. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatr Infect Dis J. 1996; 15:525-529
28. Kayhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type B. J Infect Dis. 1983;147:1100
29. Black SB, Shinefield HR, Lampert D, et al. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. Pediatr Infect Dis J. 1991;10:92-96
30. Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local responses. J Infect Dis. 1990;162:1291-1297
31. American Academy of Pediatrics, Committee on Infectious Diseases. Update on timing of hepatitis B vaccination for premature infants and for children with lapsed immunization. Pediatrics. 1994;94:403-404
32. Edwards KM, Decker MD, Halsey NA, et al. Differences in antibody responses to whole-cell pertussis vaccines. 1991;88:1019-1023
33. American Academy of Pediatrics, Committee on Infectious Diseases. Recommended childhood immunization schedule-United States, January-December 1997. Pediatrics. 1997;99:136-137
34. Greco E, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med. 1996;334:341-348
35. Daum RS. Efficacy of the combined diphtheria-tetanus toxoidspertussis-Haemophilus conjugate vaccine. Pediatr Infect Dis J. 1995;14: 640-641
36. Lau Y, Tam AYC, Ng KW, et al. Response of preterm infants to hepatitis B vaccine. J Pediatr. 1992;121:962-965
37. Kim SC, Chung EK, Hodinka RL, et al. Immunogenicity of hepatitis B vaccine in preterm infants. 1997;99:534-536